...
首页> 外文期刊>Journal of applied toxicology >Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
【24h】

Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.

机译:使用增殖试验评估络合剂对铍毒性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Occupational exposure to beryllium may cause chronic beryllium disease (CBD), a granulomatous interstitial pneumonitis caused by a cell-mediated immune response with delayed hypersensitivity initiated by an electrostatic interaction with the MHC class II human leukocyte antigen (HLA). Increased research efforts focus on the development of a CBD treatment by chelation therapy. This work presents an in vitro evaluation of the beneficial effects of beryllium chelation with different organic substrates. We have used a standard beryllium lymphocyte proliferation test (BeLPT) adapted for mouse splenocytes. Three complexing agents, 4,5-dihydroxy-1,3-benzenedisulfonic acid (tiron), nitrilotripropionic acid (NTP) and nitrilotriacetic acid (NTA), were tested using different protocols of the splenocyte proliferation test (SPT). We studied their corrective effect (beryllium pre-exposed splenocytes), their protective effect (ligand pre-exposed splenocytes) and their combined effects at fixed Be:L ratio of 1:2, at fixed Be concentration and at fixed L concentration. We also studied the effect of tiron in preventing splenocyte sensitization to beryllium. All three complexing agents showed a corrective effect and proved efficient in the combined effects, except NTA in the fixed Be:L ratio. Only NTP and tiron showed a significant protection at lower beryllium concentrations, while NTA was not significant. Splenocytes pre-exposed to chelated beryllium did not show sensitization while splenocytes pre-exposed to beryllium were sensitized. We observed a strong correlation between the efficiency of the complexing agent and its affinity towards beryllium. Both tiron and NTP showed a similar affinity towards the beryllium ion that is 10(7) higher than that of NTA. Copyright (c) 2008 John Wiley & Sons, Ltd.
机译:职业接触铍可能会导致慢性铍病(CBD),这是一种肉芽肿性间质性肺炎,由细胞介导的免疫反应引起,并与MHC II类人类白细胞抗原(HLA)发生静电相互作用,导致迟发型超敏反应。越来越多的研究工作集中在通过螯合疗法开发CBD疗法上。这项工作提出了铍螯合与不同有机底物的有益作用的体外评估。我们已经使用了适用于小鼠脾细胞的标准铍淋巴细胞增殖测试(BeLPT)。使用脾细胞增殖测试(SPT)的不同方案测试了三种络合剂4,5,5-二羟基-1,3-苯二磺酸(tiron),次氮基三丙酸(NTP)和次氮基三乙酸(NTA)。我们研究了它们的校正作用(铍预先暴露的脾细胞),其保护作用(配体预先暴露的脾细胞)以及在固定的Be:L比为1:2,固定的Be浓度和固定的L浓度下的综合作用。我们还研究了铁蛋白在预防脾细胞对铍致敏方面的作用。除NTA固定的Be:L比例外,所有三种络合剂均显示出纠正作用并证明在合并作用中有效。在较低的铍浓度下,只有NTP和tiron表现出显着的保护作用,而NTA则不显着。预先暴露于螯合铍的脾细胞未显示致敏性,而预先暴露于铍的脾细胞被致敏。我们观察到络合剂的效率与其对铍的亲和力之间有很强的相关性。钛和NTP对铍离子的亲和力相似,比NTA高10(7)。版权所有(c)2008 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号